Joe Ciaffoni, Collegium Pharmaceutical CEO (via Collegium website)

Small pain drug play­er gets snapped up in $604M buy­out — and the axe will soon fall

The small pain ther­a­py play­er BioDe­liv­ery Sci­ences is get­ting scooped up in a $604 mil­lion buy­out.

Col­legium Phar­ma­ceu­ti­cal, a some­what larg­er play­er in the pain …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.